[Thromboembolism prophylaxis with reduced bleeding risk. Trials with heparin-dihydroergot 2500].
D004087:Dihydroergotamine / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D013923:Thromboembolism / Q000517:prevention & control*
D004338:Drug Combinations; D004087:Dihydroergotamine; D006493:Heparin
Thromboembolieprophylaxe mit vermindertem Blutungsrisiko. Untersuchungen mit Heparin-Dihydergot 2500.